The author replies

New England Journal of Medicine

Volumn 359, Issue 9, 2008, Pages 973-974

  Beckett, Nigel S ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; INDAPAMIDE; PERINDOPRIL; PLACEBO;

CARDIOVASCULAR RISK; DEMENTIA; DRUG SAFETY; HUMAN; HYPERTENSION; LETTER; MASS SCREENING; MORTALITY; ORTHOSTATIC HYPOTENSION; POPULATION RESEARCH; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; UNSPECIFIED SIDE EFFECT;

EID: 50449090223     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: None     Document Type: Letter

References (2)

1. Lagakos SW. The challenge of subgroup analyses - reporting without distorting. N Engl J Med 2006;354:1667-9. [Erratum, N Engl J Med 2006;355:533.]
2. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 2001;358:1033-41. [Errata, Lancet 2001;358:1556, 2002;359:2120.]